Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

EditForce, a Japan-based creator of DNA and RNA drug development technology, raised $4.5m in funding yesterday from structural wood members manufacturer Yoshimei, MP Healthcare Venture Management and FFG Venture Investment. The commitment is an extension to the $7.3m round led by Newton Biocapital in May 2021, when University of Tokyo Edge Capital (UTEC), Itochu Technology…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.